Total Payments
$2,811
2024 Payments
$245.71
Companies
25
Transactions
123
Medicare Patients
5,326
Medicare Billing
$739,490
Payment Breakdown by Category
Food & Beverage$2,726 (97.0%)
Education$84.44 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,726 | 121 | 97.0% |
| Education | $84.44 | 2 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $384.65 | 21 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $313.24 | 12 | $0 (2024) |
| Medtronic Vascular, Inc. | $307.60 | 4 | $0 (2019) |
| PFIZER INC. | $225.34 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $214.24 | 15 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $165.98 | 10 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $151.30 | 9 | $0 (2024) |
| ABIOMED | $133.75 | 1 | $0 (2019) |
| CVRx, Inc. | $131.64 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $109.68 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.71 | 12 | E.R. Squibb & Sons, L.L.C. ($67.12) |
| 2023 | $480.05 | 16 | CVRx, Inc. ($131.64) |
| 2022 | $395.47 | 19 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($122.48) |
| 2021 | $573.40 | 35 | Janssen Pharmaceuticals, Inc ($98.00) |
| 2020 | $189.72 | 11 | Amarin Pharma Inc. ($39.96) |
| 2019 | $250.53 | 9 | ABIOMED ($133.75) |
| 2018 | $281.02 | 13 | Novartis Pharmaceuticals Corporation ($102.79) |
| 2017 | $395.02 | 8 | Medtronic Vascular, Inc. ($281.40) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.37 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.91 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/09/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/10/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Varithena_PI | ||||||
| 06/30/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $33.88 | General |
| Category: VTE | ||||||
| 06/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Cardiovascular | ||||||
| 06/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: Cardiovascular | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $35.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: Cardiovascular | ||||||
| 12/19/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: Cardiovascular | ||||||
| 11/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/10/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: DIABETES | ||||||
| 05/24/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $14.31 | General |
| Category: Cardiovascular Device | ||||||
| 05/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardiology | ||||||
| 05/11/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Rare Disease | ||||||
| 03/08/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $86.03 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/02/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $131.64 | General |
| Category: Heart Failure and Hypertension | ||||||
| 02/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,012 | 1,724 | $533,510 | $147,397 |
| 2022 | 19 | 1,423 | 2,350 | $770,595 | $211,677 |
| 2021 | 19 | 1,293 | 2,117 | $624,390 | $186,948 |
| 2020 | 21 | 1,598 | 2,497 | $690,210 | $193,469 |
Total Patients
5,326
Total Services
8,688
Medicare Billing
$739,490
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 204 | 446 | $142,930 | $54,317 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 289 | $72,250 | $25,693 | 35.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 116 | 120 | $100,200 | $16,905 | 16.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 28 | 28 | $37,950 | $9,406 | 24.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 138 | $41,400 | $8,138 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $17,200 | $5,789 | 33.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 43 | $20,425 | $5,549 | 27.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 29 | 58 | $11,420 | $5,036 | 44.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 41 | $15,375 | $3,894 | 25.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 16 | 64 | $9,600 | $2,850 | 29.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $13,440 | $2,656 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 51 | 52 | $23,140 | $2,582 | 11.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 161 | 179 | $10,760 | $1,824 | 17.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 33 | 33 | $12,540 | $1,587 | 12.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 12 | 74 | $2,220 | $678.58 | 30.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 17 | 84 | $1,260 | $352.80 | 28.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 14 | 14 | $1,400 | $139.86 | 10.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 250 | 499 | $159,680 | $65,049 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 192 | 278 | $69,500 | $26,729 | 38.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 70 | 70 | $94,500 | $25,141 | 26.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 318 | $95,400 | $17,980 | 18.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 88 | 96 | $38,850 | $14,746 | 38.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 102 | 103 | $86,005 | $13,780 | 16.0% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 70 | 123 | $23,985 | $11,405 | 47.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 45 | 179 | $26,850 | $8,655 | 32.2% |
About Dr. Chituru Adele, MD
Dr. Chituru Adele, MD is a Cardiovascular Disease healthcare provider based in Riverdale, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477500734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chituru Adele, MD has received a total of $2,811 in payments from pharmaceutical and medical device companies, with $245.71 received in 2024. These payments were reported across 123 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,726).
As a Medicare-enrolled provider, Adele has provided services to 5,326 Medicare beneficiaries, totaling 8,688 services with total Medicare billing of $739,490. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Riverdale, GA
- Active Since 05/30/2006
- Last Updated 09/23/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477500734
Products in Payments
- ENTRESTO (Drug) $342.81
- LifeVest (Device) $313.24
- Resolute (Device) $281.40
- XARELTO (Drug) $214.24
- ELIQUIS (Drug) $208.79
- OPSUMIT (Drug) $147.89
- Impella (Device) $133.75
- Barostim Neo System (Device) $131.64
- VYNDAQEL (Drug) $115.19
- Verquvo (Drug) $94.37
- Repatha (Biological) $83.22
- Vascepa (Drug) $59.40
- NEXLETOL (Drug) $57.98
- CAMZYOS (Drug) $52.66
- FARXIGA (Drug) $52.03
- VERQUVO (Drug) $43.44
- JARDIANCE (Drug) $42.27
- LEQVIO (Drug) $41.84
- BRILINTA (Drug) $35.77
- FLOWTRIEVER CATHETER, S (Device) $33.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Riverdale
Dr. Tanveer Malik, Md, MD
Cardiovascular Disease — Payments: $4,666
Cardiovascular Disease $4,666
Dr. Minnette Williams, M.d, M.D
Cardiovascular Disease — Payments: $3,219
Cardiovascular Disease $3,219
Dr. Kandathil Mathew, M.d, M.D
Cardiovascular Disease — Payments: $2,820
Cardiovascular Disease $2,820
Dr. Barry Dix, M.s, M.S
Cardiovascular Disease — Payments: $1,833
Cardiovascular Disease $1,833
Dr. Abiodun Olatidoye, M.d, M.D
Cardiovascular Disease — Payments: $527.13
Cardiovascular Disease $527.13
Kallukalam Mathew, M.d, M.D
Cardiovascular Disease — Payments: $320.54
Cardiovascular Disease $320.54